AbbVie's $46.5 Billion Bid for Shire Rejected

June 20 (Bloomberg) -- AbbVie Inc., the U.S. drugmaker split last year from Abbott Laboratories, said three escalating offers to buy Shire Plc for as much as 27.3 billion pounds ($46.5 billion) were rejected by the Dublin-based company. Matt Campbell reports on Bloomberg Television's "On the Move" with Anna Edwards. (Source: Bloomberg)
Twitter's CEO Search: Who Are the Leading Candidates?
27:30 - Spark Capital's Nabeel Hyatt, IDC's Crawford Del Prete and Bloomberg's Sarah Frier discuss Twitter's CEO search with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Will FED "Jell" on September Liftoff?
  • Stocks Rebound: What to Expect for the Rest of the Year
  • Investor Sees 'Smile' for Economy in Dental Visits